Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity

ACS Symposium Series

Volumn 1095, Issue , 2012, Pages 1-19

  Mookherjee, Neeloffer ^a   Chow, Leola N Y ^a   Hancock, Robert E W ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICROORGANISMS;

ANTI-BIOFILM; ANTI-INFLAMMATORY ACTIVITY; ANTIMICROBIAL PEPTIDE; CATIONIC PEPTIDES; IMMUNOMODULATORY; INFLAMMATORY DISORDERS; THERAPEUTIC APPLICATION;

PEPTIDES;

EID: 84905572998     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2012-1095.ch001     Document Type: Conference Paper

References (89)

1. Hadley, E. B.; Hancock, R. E. W. Strategies for the discovery and advancement of novel cationic antimicrobial peptides. Curr. Top. Med. Chem. 2010, 10 (18), 1872-81.
2. Bevins, C. L.; Salzman, N. H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 2011, 9 (5), 356-68.
3. Hancock, R. E. W.; Chapple, D. S. Peptide antibiotics. Antimicrob. Agents Chemother. 1999, 43 (6), 1317-23.
4. Lai, Y.; Gallo, R. L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30 (3), 131-41.
5. Murakami, M.; Ohtake, T.; Dorschner, R. A.; Gallo, R. L. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 2002, 81 (12), 845-50.
6. Murakami, M.; Ohtake, T.; Dorschner, R. A.; Schittek, B.; Garbe, C.; Gallo, R. L. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 2002, 119 (5), 1090-5.
7. Murakami, M.; Dorschner, R. A.; Stern, L. J.; Lin, K. H.; Gallo, R. L. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res. 2005, 57 (1), 10-5.
8. Phadke, S. M.; Deslouches, B.; Hileman, S. E.; Montelaro, R. C.; Wiesenfeld, H. C.; Mietzner, T. A. Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection. J. Nutr. 2005, 135 (5), 1289-93.
9. Scott, M. G.; Dullaghan, E.; Mookherjee, N.; Glavas, N.; Waldbrook, M.; Thompson, A.; Wang, A.; Lee, K.; Doria, S.; Hamill, P.; Yu, J. J.; Li, Y.; Donini, O.; Guarna, M. M.; Finlay, B. B.; North, J. R.; Hancock, R. E. W. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 2007, 25 (4), 465-72.
10. Nijnik, A.; Madera, L.; Ma, S.; Waldbrook, M.; Elliott, M. R.; Easton, D. M.; Mayer, M. L.; Mullaly, S. C.; Kindrachuk, J.; Jenssen, H.; Hancock, R. E. W. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 2010, 184 (5), 2539-50.
11. Easton, D. M.; Nijnik, A.; Mayer, M. L.; Hancock, R. E. W. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 2009, 27 (10), 582-90.
12. Hancock, R. E. W.; Sahl, H. G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24 (12), 1551-7.
13. Overhage, J.; Campisano, A.; Bains, M.; Torfs, E. C.; Rehm, B. H.; Hancock, R. E. W. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 2008, 76 (9), 4176-82.
14. Hilpert, K.; Elliott, M.; Jenssen, H.; Kindrachuk, J.; Fjell, C. D.; Korner, J.; Winkler, D. F.; Weaver, L. L.; Henklein, P.; Ulrich, A. S.; Chiang, S. H.; Farmer, S. W.; Pante, N.; Volkmer, R.; Hancock, R. E. W. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem. Biol. 2009, 16 (1), 58-69.
15. Bowdish, D. M.; Davidson, D. J.; Lau, Y. E.; Lee, K.; Scott, M. G.; Hancock, R. E. W. Impact of LL-37 on anti-infective immunity. J. Leukocyte Biol. 2005, 77 (4), 451-9.
16. Mookherjee, N.; Hancock, R. E. W. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 2007, 64 (7-8), 922-33.
17. Hirsch, T.; Jacobsen, F.; Steinau, H. U.; Steinstraesser, L. Host defense peptides and the new line of defence against multiresistant infections. Protein Pept. Lett. 2008, 15 (3), 238-43.
18. Steinstraesser, L.; Koehler, T.; Jacobsen, F.; Daigeler, A.; Goertz, O.; Langer, S.; Kesting, M.; Steinau, H.; Eriksson, E.; Hirsch, T. Host defense peptides in wound healing. Mol. Med. 2008, 14 (7-8), 528-37.
19. Mookherjee, N.; Brown, K. L.; Bowdish, D. M.; Doria, S.; Falsafi, R.; Hokamp, K.; Roche, F. M.; Mu, R.; Doho, G. H.; Pistolic, J.; Powers, J. P.; Bryan, J.; Brinkman, F. S.; Hancock, R. E. W. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006, 176 (4), 2455-64.
20. Oppenheim, J. J.; Biragyn, A.; Kwak, L. W.; Yang, D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann. Rheum. Dis. 2003, 62 (Suppl 2), ii17-21.
21. Bowdish, D. M.; Davidson, D. J.; Hancock, R. E. W. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 2005, 6 (1), 35-51.
22. Davidson, D. J.; Currie, A. J.; Reid, G. S.; Bowdish, D. M.; MacDonald, K. L.; Ma, R. C.; Hancock, R. E. W.; Speert, D. P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 2004, 172 (2), 1146-56.
23. Bowdish, D. M.; Davidson, D. J.; Hancock, R. E. W. Immunomodulatory properties of defensins and cathelicidins. Curr. Top Microbiol. Immunol. 2006, 306, 27-66.
24. Cao, D.; Li, H.; Jiang, Z.; Xu, C.; Cheng, Q.; Yang, Z.; Cao, G.; Zhang, L. Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets. Vaccine 2010, 28 (37), 6006-13.
25. Powers, J. P.; Hancock, R. E. W. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24 (11), 1681-91.
26. Cherkasov, A.; Hilpert, K.; Jenssen, H.; Fjell, C. D.; Waldbrook, M.; Mullaly, S. C.; Volkmer, R.; Hancock, R. E. W. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol. 2009, 4 (1), 65-74.
27. Hilpert, K.; Volkmer-Engert, R.; Walter, T.; Hancock, R. E. W. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 2005, 23 (8), 1008-12.
28. Wieczorek, M.; Jenssen, H.; Kindrachuk, J.; Scott, W. R.; Elliott, M.; Hilpert, K.; Cheng, J. T.; Hancock, R. E. W.; Straus, S. K. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 2010, 17 (9), 970-80.
29. Rajanbabu, V.; Chen, J. Y. Antiviral function of tilapia hepcidin 1-5 and its modulation of immune-related gene expressions against infectious pancreatic necrosis virus (IPNV) in Chinook salmon embryo (CHSE)-214 cells. Fish Shellfish Immunol. 2011, 30 (1), 39-44.
30. Kindrachuk, J.; Scruten, E.; Attah-Poku, S.; Bell, K.; Potter, A.; Babiuk, L. A.; Griebel, P. J.; Napper, S. Stability, toxicity and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers. Biopolymers 2011, 96 (1), 14-24.
31. Ohta, K.; Kajiya, M.; Zhu, T.; Nishi, H.; Mawardi, H.; Shin, J.; Elbadawi, L.; Kamata, N.; Komatsuzawa, H.; Kawai, T. Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities. J. Neuroimmunol. 2011, 233 (1-2), 37-45.
32. Arnett, E.; Lehrer, R. I.; Pratikhya, P.; Lu, W.; Seveau, S. Defensins enable macrophages to inhibit the intracellular proliferation of Listeria monocytogenes. Cell Microbiol. 2011, 13 (4), 635-51.
33. Falco, A.; Ortega-Villaizan, M.; Chico, V.; Brocal, I.; Perez, L.; Coll, J. M.; Estepa, A. Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture. Mini-Rev. Med. Chem. 2009, 9 (10), 1159-64.
34. Haines, L. R.; Hancock, R. E. W.; Pearson, T. W. Cationic antimicrobial peptide killing of African trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness. Vector Borne Zoonotic Dis. 2003, 3 (4), 175-86.
35. Morrison, G.; Kilanowski, F.; Davidson, D.; Dorin, J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 2002, 70 (6), 3053-60.
36. Putsep, K.; Carlsson, G.; Boman, H. G.; Andersson, M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002, 360 (9340), 1144-9.
37. Salzman, N. H.; Ghosh, D.; Huttner, K. M.; Paterson, Y.; Bevins, C. L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003, 422 (6931), 522-6.
38. Ganz, T.; Metcalf, J. A.; Gallin, J. I.; Boxer, L. A.; Lehrer, R. I. Microbicidal/ cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J. Clin. Invest. 1988, 82 (2), 552-6.
39. Bals, R.; Weiner, D. J.; Moscioni, A. D.; Meegalla, R. L.; Wilson, J. M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 1999, 67 (11), 6084-9.
40. Jones, A. M.; Helm, J. M. Emerging treatments in cystic fibrosis. Drugs 2009, 69 (14), 1903-10.
41. Liu, P. T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B. H.; Krutzik, S. R.; Ochoa, M. T.; Schauber, J.; Wu, K.; Meinken, C.; Kamen, D. L.; Wagner, M.; Bals, R.; Steinmeyer, A.; Zugel, U.; Gallo, R. L.; Eisenberg, D.; Hewison, M.; Hollis, B. W.; Adams, J. S.; Bloom, B. R.; Modlin, R. L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 5768, 1770-3.
42. Gombart, A. F. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009, 4 (9), 1151-65.
43. Schauber, J.; Dorschner, R. A.; Coda, A. B.; Buchau, A. S.; Liu, P. T.; Kiken, D.; Helfrich, Y. R.; Kang, S.; Elalieh, H. Z.; Steinmeyer, A.; Zugel, U.; Bikle, D. D.; Modlin, R. L.; Gallo, R. L. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117 (3), 803-11.
44. Steinstraesser, L.; Kraneburg, U.; Jacobsen, F.; Al-Benna, S. Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011, 216 (3), 322-33.
45. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415 (6870), 389-95.
46. Zhang, L.; Scott, M. G.; Yan, H.; Mayer, L. D.; Hancock, R. E. W. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry 2000, 39 (47), 14504-14.
47. Hale, J. D.; Hancock, R. E. W. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti-Infect Ther 2007, 5 (6), 951-9.
48. Bera, A.; Singh, S.; Nagaraj, R.; Vaidya, T. Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides. Mol. Biochem. Parasitol. 2003, 127 (1), 23-35.
49. Mookherjee, N.; Rehaume, L. M.; Hancock, R. E. W. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007, 11 (8), 993-1004.
50. Sawa, T.; Kurahashi, K.; Ohara, M.; Gropper, M. A.; Doshi, V.; Larrick, J. W.; Wiener-Kronish, J. P. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob. Agents Chemother. 1998, 42 (12), 3269-75.
51. Gallo, R. L. Sounding the alarm: multiple functions of host defense peptides. J. Invest. Dermatol. 2008, 128 (1), 5-6.
52. Scott, M. G.; Davidson, D. J.; Gold, M. R.; Bowdish, D.; Hancock, R. E. W. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 2002, 169 (7), 3883-91.
53. Bowdish, D. M.; Davidson, D. J.; Scott, M. G.; Hancock, R. E. W. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 2005, 49 (5), 1727-32.
54. Bowdish, D. M.; Davidson, D. J.; Speert, D. P.; Hancock, R. E. W. The human cationic peptide LL-37 induces activation of the extracellular signalregulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 2004, 172 (6), 3758-65.
55. Yu, J.; Mookherjee, N.; Wee, K.; Bowdish, D. M.; Pistolic, J.; Li, Y.; Rehaume, L.; Hancock, R. E. W. Host Defense Peptide LL-37, in Synergy with Inflammatory Mediator IL-1beta, Augments Immune Responses by Multiple Pathways. J. Immunol. 2007, 179 (11), 7684-91.
56. Dong, C.; Davis, R. J.; Flavell, R. A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20, 55-72.
57. Wehkamp, J.; Schmid, M.; Stange, E. F. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr. Opin. Gastroenterol. 2007, 23 (4), 370-8.
58. Zilbauer, M.; Jenke, A.; Wenzel, G.; Postberg, J.; Heusch, A.; Phillips, A. D.; Noble-Jamieson, G.; Torrente, F.; Salvestrini, C.; Heuschkel, R.; Wirth, S. Expression of human beta-defensins in children with chronic inflammatory bowel disease. PLoS One 2010, 5 (10), e15389.
59. Peric, M.; Koglin, S.; Dombrowski, Y.; Gross, K.; Bradac, E.; Buchau, A.; Steinmeyer, A.; Zugel, U.; Ruzicka, T.; Schauber, J. Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One 2009, 4 (7), e6340.
60. Ong, P. Y.; Ohtake, T.; Brandt, C.; Strickland, I.; Boguniewicz, M.; Ganz, T.; Gallo, R. L.; Leung, D. Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 2002, 347 (15), 1151-60.
61. Rieg, S.; Steffen, H.; Seeber, S.; Humeny, A.; Kalbacher, H.; Dietz, K.; Garbe, C.; Schittek, B. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J. Immunol. 2005, 174 (12), 8003-10.
62. Gilliet, M.; Lande, R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 2008, 20 (4), 401-7.
63. Bokarewa, M. I.; Jin, T.; Tarkowski, A. Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J. Rheumatol. 2003, 30 (8), 1719-24.
64. Dybvig, T.; Facci, M.; Gerdts, V.; Wilson, H. L. Biological roles of host defense peptides: lessons from transgenic animals and bioengineered tissues. Cell Tissue Res. 2011, 343 (1), 213-25.
65. Scott, M. G.; Rosenberger, C. M.; Gold, M. R.; Finlay, B. B.; Hancock, R. E. W. An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J. Immunol. 2000, 165 (6), 3358-65.
66. Mookherjee, N.; Hamill, P.; Gardy, J.; Blimkie, D.; Falsafi, R.; Chikatamarla, A.; Arenillas, D. J.; Doria, S.; Kollmann, T. R.; Hancock, R. E. W. Systems biology evaluation of immune responses induced by human host defence peptide LL-37 in mononuclear cells. Mol. Biosyst. 2009, 5 (5), 483-96.
67. Mookherjee, N.; Wilson, H. L.; Doria, S.; Popowych, Y.; Falsafi, R.; Yu, J. J.; Li, Y.; Veatch, S.; Roche, F. M.; Brown, K. L.; Brinkman, F. S.; Hokamp, K.; Potter, A.; Babiuk, L. A.; Griebel, P. J.; Hancock, R. E. W. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J. Leukoc. Biol. 2006, 80 (6), 1563-74.
68. Mookherjee, N.; Lippert, D. N.; Hamill, P.; Falsafi, R.; Nijnik, A.; Kindrachuk, J.; Pistolic, J.; Gardy, J.; Miri, P.; Naseer, M.; Foster, L. J.; Hancock, R. E. W. Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 2009, 183 (4), 2688-96.
69. Lau, Y. E.; Rozek, A.; Scott, M. G.; Goosney, D. L.; Davidson, D. J.; Hancock, R. E. W. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 2005, 73 (1), 583-91.
70. Yu, H. B.; Kielczewska, A.; Rozek, A.; Takenaka, S.; Li, Y.; Thorson, L.; Hancock, R. E. W.; Guarna, M. M.; North, J. R.; Foster, L. J.; Donini, O.; Finlay, B. B. Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. J. Biol. Chem. 2009, 284 (52), 36007-11.
71. De, Y.; Chen, Q.; Schmidt, A. P.; Anderson, G. M.; Wang, J. M.; Wooters, J.; Oppenheim, J. J.; Chertov, O. LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 2000, 192 (7), 1069-74.
72. Bandholtz, L.; Ekman, G. J.; Vilhelmsson, M.; Buentke, E.; Agerberth, B.; Scheynius, A.; Gudmundsson, G. H. Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype. Scand. J. Immunol. 2006, 63 (6), 410-9.
73. Hancock, R. E. W.; Rozek, A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002, 206 (2), 143-9.
74. Brandenburg, L. O.; Jansen, S.; Wruck, C. J.; Lucius, R.; Pufe, T. Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways. Mol. Immunol. 2010, 47 (10), 1905-13.
75. Niyonsaba, F.; Someya, A.; Hirata, M.; Ogawa, H.; Nagaoka, I. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J. Immunol. 2001, 31 (4), 1066-75.
76. Koczulla, R.; von Degenfeld, G.; Kupatt, C.; Krotz, F.; Zahler, S.; Gloe, T.; Issbrucker, K.; Unterberger, P.; Zaiou, M.; Lebherz, C.; Karl, A.; Raake, P.; Pfosser, A.; Boekstegers, P.; Welsch, U.; Hiemstra, P. S.; Vogelmeier, C.; Gallo, R. L.; Clauss, M.; Bals, R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 2003, 111 (11), 1665-72.
77. Heilborn, J. D.; Nilsson, M. F.; Kratz, G.; Weber, G.; Sorensen, O.; Borregaard, N.; Stahle-Backdahl, M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 2003, 120 (3), 379-89.
78. Winthrop, K. L. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat. Clin. Pract. Rheumatol. 2006, 2 (11), 602-10.
79. Botsios, C. Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmun. Rev. 2005, 4 (3), 162-70.
80. Lillard, J. W., Jr.; Boyaka, P. N.; Chertov, O.; Oppenheim, J. J.; McGhee, J. R. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (2), 651-6.
81. Tani, K.; Murphy, W. J.; Chertov, O.; Salcedo, R.; Koh, C. Y.; Utsunomiya, I.; Funakoshi, S.; Asai, O.; Herrmann, S. H.; Wang, J. M.; Kwak, L. W.; Oppenheim, J. J. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int. Immunol. 2000, 12 (5), 691-700.
82. Kovacs-Nolan, J.; Mapletoft, J. W.; Latimer, L.; Babiuk, L. A.; Hurk, S. D. CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle. Vaccine 2009, 27 (14), 2048-54.
83. Kindrachuk, J.; Jenssen, H.; Elliott, M.; Townsend, R.; Nijnik, A.; Lee, S. F.; Gerdts, V.; Babiuk, L. A.; Halperin, S. A.; Hancock, R. E. W. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 2009, 27 (34), 4662-71.
84. Yeung, A. T.; Gellatly, S. L.; Hancock, R. E. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol. Life Sci. 2011, 68 (13), 2161-76.
85. Hancock, R. E. W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1 (3), 156-64.
86. McPhee, J. B.; Hancock, R. E. W. Function and therapeutic potential of host defence peptides. J. Pept. Sci. 2005, 11 (11), 677-87.
87. Zhang, H.; Porro, G.; Orzech, N.; Mullen, B.; Liu, M.; Slutsky, A. S. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280 (5), L947-54.
88. Kruse, T.; Kristensen, H. H. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents. Expert. Rev. Anti-Infect. Ther. 2008, 6 (6), 887-95.
89. Bommarius, B.; Jenssen, H.; Elliott, M.; Kindrachuk, J.; Pasupuleti, M.; Gieren, H.; Jaeger, K. E.; Hancock, R. E. W.; Kalman, D. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 2010, 31 (11), 1957-65.